Biglycan Antikörper (Precursor)
Kurzübersicht für Biglycan Antikörper (Precursor) (ABIN646099)
Target
Alle Biglycan (BGN) Antikörper anzeigenReaktivität
Wirt
Konjugat
Applikation
-
-
Bindungsspezifität
- Precursor
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus), Hund
-
Produktmerkmale
- Goat Anti-Biglycan Preproprotein
-
Immunogen
- Peptide with sequence C-DRLAIQFGNYKK, from the C Terminus of the protein sequence according to NP_001702.1.
-
-
-
-
Applikationshinweise
- Immunoassay (ELISA, Western blotting): 1:5,000-1:10,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- Biglycan (BGN)
-
Andere Bezeichnung
- Biglycan Preproprotein
-
Hintergrund
- Synonyms: small leucine-rich protein 1A, dermatan sulphate proteoglycan I, bone/cartilage proteoglycan-I, SLRR1A, PGI, PG-S1, DSPG1, BGN, biglycan, Biglycan Preproprotein
-
Gen-ID
- 633
-
NCBI Accession
- NP_001702
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-